We are live on ! Find out more
CFS

Cannon Financial Strategists Portfolio holdings

AUM $879M
1-Year Est. Return 22.04%
This Fund
S&P 500
This Quarter Est. Return
-1.42%
1 Year Est. Return
+22.04%
3 Year Est. Return
+52.38%
5 Year Est. Return
+43.2%
10 Year Est. Return
AUM
$583M
AUM Growth
+$11.2M
Cap. Flow
+$20.9M
Cap. Flow %
3.59%
Top 10 Hldgs %
75.92%
Holding
101
New
3
Increased
51
Reduced
16
Closed
5
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDP
101
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
-39,521
Closed -$996K

Similar funds

Cannon Financial Strategists's Q4 2024 Portfolio in Review

As of Q4 2024, Cannon Financial Strategists held 101 positions worth $583M, up 2% from $572M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Cannon Financial Strategists deployed $20.9M of net new capital in Q4 2024, opening 3 new positions and adding to 51 existing holdings. Its largest new stake was Rhythm Pharmaceuticals: 10,000 shares worth $560K.

By sector, the portfolio is most concentrated in Consumer Staples at 1.1% of assets, down from 1.2% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $184K trimmed.

  • Cannon Financial Strategists's largest Q4 2024 buy was Rhythm Pharmaceuticals: 10,000 shares worth $560K.
  • Cannon Financial Strategists added most to Capital Group Core Bond ETF in Q4 2024, an estimated $6.56M increase.
  • Cannon Financial Strategists's biggest Q4 2024 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $184K.
  • Cannon Financial Strategists fully exited iShares iBonds Dec 2024 Term Treasury ETF in Q4 2024, selling an estimated $1.5M.
  • Cannon Financial Strategists's ten largest holdings make up 76% of its $583M portfolio in Q4 2024.
  • Cannon Financial Strategists opened 3 new positions and closed 5 in Q4 2024.
  • Cannon Financial Strategists's portfolio value rose 2% quarter-over-quarter to $583M.

Based on Cannon Financial Strategists's 13F filing for Q4 2024, filed 3 Feb 2025.